Webcode 25092002
Yves Koch
Pfizer, SWITZERLAND
Director Global Access Strategy & Pricing Oncology; with 15 years in market access, he has specialized in crafting thorough global pricing and reimbursement strategies, particularly for key Oncology products, guaranteeing optimal access for patients. His expertise includes hands-on negotiation with payers, securing favorable agreements across regions like Germany, the Nordics, Austria and Switzerland.
Dr. Florian Csintalan
Otsuka
More than 10 years of experience in HTA, market access, and evidence strategy. His career has taken him from local and global roles at Roche, where he contributed to numerous HTA submissions and led cross-functional initiatives to global consulting at Clinigen, and now to his current position as Senior Manager Market Access DACH at Otsuka. He is passionate about translating complex data into meaningful access strategies that make a real difference for patients, payers and pharmaceutical companies.
Pietro Sternini
Covis Pharma, SWITZERLAND
Market Access & Marketing Lead, EMEA Pietro Sternini worked in various Market Access, HEOR and Marketing roles at Atara Biotherapeutics, Alexion Europe, Novartis Oncology Europe as well as Global Novartis Cell & Gene Unit in the US. He holds a MA in Healthcare Business Administration from the Catholic University in Rome, an intra-faculty Economics-Medicine course focused on health policy, health economics and hospital management.
29/09/2025
29/09/2025
9:00 am - 5:00 pm online seminar
You may dial in 30 minutes in advance
online
online
Veranstaltung - 1,290 € zzgl. MwSt.
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Veranstaltung - 1,290 € zzgl. MwSt.
The fee includes high-quality course material for download, a certificate of participation, access to our Learning Space and technical support, including a test meeting.
Dr. Henriette Wolf-Klein
Head of Department
+49 6221 500-680
h.wolf-klein@forum-institut.de
You will gain actionable insights into global pricing, market access strategies, payer evidence requirements, and health economic tools - enabling you to support strategic decision-making across diverse healthcare systems.
This compact course offers a comprehensive overview of commercial models, pricing strategies, and market access pathways within the global healthcare environment.
Participants will explore essential aspects such as licensing models, payer evidence generation, value-based healthcare systems, and health technology assessments.
Through expert-led sessions and practical case discussions, the course enables participants to critically assess value propositions, apply health economic tools, and understand pricing frameworks. Special focus will be placed on the integration of real-world evidence, global and local HTA synergies, and communication strategies tailored to payer expectations.
By the end of the seminar, participants will be equipped to support the design of a robust international pricing and market access strategy.
of 5 stars of all ratings from 2024
of 5 stars on Trustpilot = good
CCDS, Lieferkettensorgfaltspflichtengesetz u.v.m. - welche Berichte müssen Sie bis wann und wie verfassen? Hier erfahren...
Sie benötigen als Einsteiger*in in der Pharma-Branche ein solides Grundlagenwissen über das deutsche Gesundheitssystem? ...
Dieses Seminar adressiert Arzneimittelpreise im Fokus der Erstattungsbetragsverhandlung bei der frühen Nutzenbewertung.
Im Rahmen des Seminars erfahren Mitarbeiter*innen von Krankenkassen und pharmazeutischen Unternehmen wie die GKV "tickt"...
Dieser Workshop macht Sie fit für die G-BA Anhörung und vermittelt statistisches Know-how zur frühen Nutzenbewertung - ...
